BIOSURFACES INC
Ashland, MA · Founded 2018 · CIK 0001734953 · Medtech · Private
electrospun nanofiber cell chamber device for immune-protected encapsulation and transplantation of pancreatic beta cells
biosurfaces.us →- Grants
- $2.3M
- 4 awards
- Sector median: 1
- Raised
- $900K
- 1 Form D · Mar 2018
- 102 months since last filing
- Contracts
- $2.3M
- 11 awards · Health and Human S
- #208 of 4531 in medtech
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2006200820102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Critical Technologies For Ventricular Assist Devices | $100,000 | |
| Federal contract | Department of Health and Human Services · Biomedical (applied/exploratory) | $738,779 | |
| Federal contract | Department of Health and Human Services · Biosurfaces, INC.:1157017 Igf::ot::igf | $24,325 | |
| Federal contract | Department of Health and Human Services · Biosurfaces, INC.:1157017 [18-001375] | $26,761 | |
| Private capital raised | Form D · SEC | $900,000 | |
| Federal contract | Department of Health and Human Services · Biosurfaces, INC.:1157017 [19-000675] | $45,816 | |
| Federal contract | Department of Health and Human Services · 96-WELL Plate Assemblies With A Biodegradable Membrane | $894,612 | |
| Federal contract | Department of Health and Human Services · Scaffold From Nre Study To Provide Npdlga Material For Use In Non-human Experiments From Biosurfaces, Inc. | $45,816 | |
| Federal contract | Department of Health and Human Services · Coronavirus - Expandable Lung Alveolar Epithelial Cells | $142,563 | |
| Federal contract | Department of Health and Human Services · Lab&testing Services For Plga Scaffolds | $5,000 | |
| Federal contract | Department of Health and Human Services · Purchase 96-WELL Plate Assemblies With Biodegradable Scaffolds (COVID-19) | $90,000 | |
| Federal contract | Department of Health and Human Services · Acquisition Of 96-WELL Transwell Plates With Proprietary Bio-spun Membrane Inserts (COVID-19) | $168,400 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds | $884,718 | |
| Federal grant | Department of Health and Human Services · Phase I · Implantable Electrospun Cell Chamber Device with Immune-Evasive Properties for Beta Cell Replacement Therapy | $275,766 | |
| Federal grant | Department of Health and Human Services · Phase I · Implantable Electrospun Cell Chamber Device with Immune-Evasive Properties for Beta Cell Replacement Therapy | $275,766 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds | $840,696 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 205 | Molekule Group, Inc. | $2.3M | $25M |
| 206 | ZYMO RESEARCH CORP. | $2.3M | — |
| 207 | ZANSORS LLC | $2.3M | — |
| 208 | BIOSURFACES INC | $2.3M | $900K |
| 209 | Oculogica Inc. | $2.2M | $22M |
| 210 | SAFETRACES, INC | $2.2M | $19M |
| 211 | INNOVATIVE SURFACE TECHNOLOGIES INC | $2.2M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Thomas BarretteDirector
- Matthew PhaneufDirector · Executive Officer
- Tina PhaneufDirector · Executive Officer
Patents
- Tissue Cuffapplication
- Method And Scaffold Device To Enable Oxygen-carbon Dioxide Exchangeapplication
- Tissue Cuffapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.